Immunoglobulin Dosage and Switch from Intravenous to Subcutaneous Immunoglobulin Replacement Therapy in Patients with Primary Hypogammaglobulinemia: Decreasing Dosage Does Not Alter Serum IgG Levels

Sylvain Thépot; Marion Malphettes; Anaëlle Gardeur; Lionel Galicier; Bouchra Asli; Lionel Karlin; Laurence Gérard; Richard Laumont; Marie-Laure Doize; Bertrand Arnulf

首页> 外文期刊>Journal of Clinical Immunology >Immunoglobulin Dosage and Switch from Intravenous to Subcutaneous Immunoglobulin Replacement Therapy in Patients with Primary Hypogammaglobulinemia: Decreasing Dosage Does Not Alter Serum IgG Levels

【24h】

Immunoglobulin Dosage and Switch from Intravenous to Subcutaneous Immunoglobulin Replacement Therapy in Patients with Primary Hypogammaglobulinemia: Decreasing Dosage Does Not Alter Serum IgG Levels

机译：免疫球蛋白的剂量以及原发性低球蛋白球蛋白血症患者从静脉内改为皮下免疫球蛋白的替代治疗：减少剂量不会改变血清IgG水平

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective The impact of reducing immunoglobulin dosage while switching from intravenous to subcutaneous replacement therapy was evaluated.

机译：目的评估减少免疫球蛋白剂量从静脉内转移到皮下替代治疗的影响。

著录项

来源
《Journal of Clinical Immunology》 |2010年第4期|p.602-606|共5页
作者
Sylvain Thépot; Marion Malphettes; Anaëlle Gardeur; Lionel Galicier; Bouchra Asli; Lionel Karlin; Laurence Gérard; Richard Laumont; Marie-Laure Doize; Bertrand Arnulf;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词
Subcutaneous immunoglobulin replacement; therapy; primary immune deficiency;

机译：皮下免疫球蛋白替代;治疗;原发性免疫缺陷;

相似文献

外文文献
中文文献
专利

1. Immunoglobulin dosage and switch from intravenous to subcutaneous immunoglobulin replacement therapy in patients with primary hypogammaglobulinemia: decreasing dosage does not alter serum IgG levels. [J] . Thepot S, Malphettes M, Gardeur A, Journal of Clinical Immunology . 2010,第4期

机译：免疫球蛋白的剂量和原发性低血球蛋白血症的患者从静脉内转移至皮下免疫球蛋白替代疗法：降低剂量不会改变血清IgG水平。
2. Correlations Among Subcutaneous Immunoglobulin Dosage, Immunoglobulin G Serum Pre-infusional Levels and Body Mass Index in Primary Antibody Deficiency Patients: A Pooled Analysis from the SHIFT/IBIS Studies [J] . Pecoraro Antonio, Ricci Silvia, Vultaggio Alessandra, Clinical drug investigation . 2020,第3期

机译：皮下免疫球蛋白剂量的相关性，免疫球蛋白G血清前动入水平和体重指数在原代抗体缺乏症患者中的综合性分析：来自转移/宜必思研究的汇总分析
3. Serial Serum Immunoglobulin G (IgG) Trough Levels in Patients with X-linked Agammaglobulinemia on Replacement Therapy with Intravenous Immunoglobulin: Its Correlation with Infections in Indian Children [J] . Suri Deepti, Bhattad Sagar, Sharma Avinash, Journal of Clinical Immunology . 2017,第3期

机译：X型激素患者患者患者血清免疫球蛋白G（IgG）槽水平对静脉内免疫球蛋白的替代疗法的替代疗法：其与印度儿童感染的相关性
4. Therapy of Patients with Chronic Immune Thrombocytopenic Purpura (ITP): Efficacy, Tolerability, and Safety of a New Nanofiltered Intravenous Immunoglobulin [C] . H.-H. Wolf, S. Davies, G. Smith, European Haematology Association . 2002

机译：慢性免疫血小板减少症患者的治疗患者（ITP）：一种新的纳米过滤静脉内免疫球蛋白的疗效，耐受性和安全性
5. Evaluation of safety and efficacy of a 20 Subcutaneous Immunoglobulin (Hizentra™) after a dose equivalent switch from intravenous or subcutaneous replacement therapy in a cohort of primary immunodeficient patients [O] . Adriana Martin, Robert Schellenberg 2012

机译：在一组原发性免疫缺陷患者中从静脉内或皮下替代治疗等效剂量转换后评估20％皮下免疫球蛋白（Hizentra™）的安全性和有效性
6. Evaluation of safety and efficacy of a 20% Subcutaneous Immunoglobulin (Hizentra™), after a dose equivalent switch from intravenous or subcutaneous replacement therapy in a cohort of primary immunodeficient patients [O] . Martin Adriana, Schellenberg Robert 2012

机译：在一组原发性免疫缺陷患者中，从静脉内或皮下替代治疗等效剂量转换后，评估20％皮下免疫球蛋白（Hizentra™）的安全性和有效性

Immunoglobulin Dosage and Switch from Intravenous to Subcutaneous Immunoglobulin Replacement Therapy in Patients with Primary Hypogammaglobulinemia: Decreasing Dosage Does Not Alter Serum IgG Levels

摘要

著录项

相似文献

相关主题

期刊订阅